KHP Capital’s AbbVie ABBV Stock Holding History

KHP Capital’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	$161K	Hold	1,700	–	–	0.1%	74
2018 Q2	$158K	Hold	1,700	–	–	0.1%	71
2018 Q1	$161K	Buy	+1,700	New	+$187K	0.11%	68

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

KHP Capital's ABBV Position: Q3 2018 in Review

KHP Capital held its AbbVie (ABBV) position steady in Q3 2018 at 1,700 shares worth $161K. The position accounts for 0.1% of the portfolio, ranked #74.

KHP Capital first reported a position in ABBV in Q1 2018 and has held it in 3 quarters since. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

KHP Capital held 1,700 shares of AbbVie worth $161K as of Q3 2018.
KHP Capital left its AbbVie share count unchanged in Q3 2018.
AbbVie made up 0.1% of KHP Capital's portfolio in Q3 2018, its #74 holding.
KHP Capital first reported a position in AbbVie in Q1 2018 and has held it in 3 quarters since.
1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on KHP Capital's 13F filing for Q3 2018, filed 8 Nov 2018.